Page 3 - Read Online
P. 3
GENERAL INFORMATION
About the Journal
Rare Disease and Orphan Drugs Journal (RDODJ), is an international peer-reviewed, open access, online journal.The Rare
Disease and Orphan Drugs Journal (RDODJ) is an international, peer-reviewed, open access journal for the publication of
innovative research works on various aspects of this rapidly growing multidisciplinary and interdisciplinary field.
RDODJ will report on scientific advances in the genetics of rare diseases, the molecular basis of the pathologies, and
translational research on diagnosis, prevention and treatment.
In addition, RDODJ aims to provide a forum for scientific studies and discussion covering the important regulatory, socio-
economic and human science issues related to rare diseases and orphan drugs.
The ultimate objective of RDODJ is to promote the dissemination of research results and scientific discussion among the
research community, practitioners, and patient-advocacy organizations.
Information for Authors
Manuscripts should be prepared in accordance with Author Instructions.
Please check www.rdodjjournal.com/pages/view/author_instructions for details.
All manuscripts should be submitted online at https://oaemesas.com/login?JournalId=rdodj.
Copyright
The entire contents of the RDODJ are protected under international copyrights. The journal, however, grants to all users
a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the
work publicly and to make and distribute derivative works in any digital medium for any reasonable purpose, subject to
proper attribution of authorship and ownership of the rights. The journal also grants the right to make small numbers of
printed copies for their personal use under the Creative Commons Attribution 4.0 License.
Copyright is reserved by © The Author(s) 2023.
Permissions
For information on how to request permissions to reproduce articles/information from this journal, please visit
www.rdodjjournal.com.
Disclaimer
The information and opinions presented in the journal reflect the views of the authors and not of the journal or its Editorial
Board or the Publisher. Publication does not constitute endorsement by the journal. Neither the RDODJ nor its publishers
nor anyone else involved in creating, producing or delivering the RDODJ or the materials contained therein, assumes any
liability or responsibility for the accuracy, completeness, or usefulness of any information provided in the RDODJ, nor
shall they be liable for any direct, indirect, incidental, special, consequential or punitive damages arising out of the use of
the RDODJ. The RDODJ, nor its publishers, nor any other party involved in the preparation of material contained in the
RDODJ represents or warrants that the information contained herein is in every respect accurate or complete, and they are
not responsible for any errors or omissions or for the results obtained from the use of such material. Readers are encouraged
to confirm the information contained herein with other sources.
Publisher
OAE Publishing Inc.
245 E Main Street st112, Alhambra, CA 91801, USA
Website: www.oaepublish.com
Contacts
E-mail: editorialoffice@rdodjjournal.com
Website: www.rdodjjournal.com
II Rare Disease and Orphan Drugs Journal | Volume 2 | Issue 3 | Sep 2023 ¦